Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 May:30 Suppl 1:S101-4.
doi: 10.1007/s10072-009-0073-3.

Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data

Affiliations
Case Reports

Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data

Alberto Proietti Cecchini et al. Neurol Sci. 2009 May.

Abstract

Drug refractory chronic daily headache (CDH) is a highly disabling condition. CDH is usually regarded as the negative evolution of chronic migraine (CM) and is characterized by high prevalence of psychiatric disorders, especially mood disorders. Vagal nerve stimulation (VNS) is an established treatment option for selected patients with medically refractory epilepsy and depression. Neurobiological similarities suggest that VNS could be useful in the treatment of drug-refractory CM associated with depression. The aim of the study was to evaluate the efficacy of VNS in patients suffering from drug-refractory CM and depressive disorder. We selected four female patients, mean age 53 (range 43-65 years), suffering from daily headache and drug-refractory CM. Neurological examination and neuroradiological investigations were unremarkable. Exclusion criteria were psychosis, heart and lung diseases. The preliminary results in our small case series support a beneficial effect of chronic VNS on both drug-refractory CM and depression, and suggest this novel treatment as a valid alternative for this otherwise intractable and highly disabling condition.

PubMed Disclaimer

References

    1. Neurol Sci. 2008 May;29 Suppl 1:S55-8 - PubMed
    1. Lancet Neurol. 2005 Sep;4(9):533-42 - PubMed
    1. Headache. 2008 Apr;48(4):501-16 - PubMed
    1. Neurology. 2002 Sep 24;59(6 Suppl 4):S31-7 - PubMed
    1. Neurol Sci. 2008 May;29 Suppl 1:S59-61 - PubMed

Publication types